About this trial
The goal of this clinical trial is to analyse the prevalence of new or uncontrolled arterial hypertension (AHT) after hospital discharge of medical in-patients with elevated blood pressure (BP) values during hospitalisation.
The main questions it aims to answer are:
* Do elevated BP values during hospitalisation correspond to new or uncontrolled AHT after hospital discharge? * Is it safe to postpone adaption of antihypertensive treatment until after proper evaluation of AHT after hospital discharge?
Participants will either be treated according to their physicians' decision or antihypertensive treatment adaptions will be postponed until after hospital discharge.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient hospitalized on the internal medicine ward for non-cardiovascular causes, i.e. patients hospitalized for conditions, which are not acutely worsened by uncontrolled AHT
Asymptomatic elevated BP values (defined as 140-180 mmHg systolic and/or 90-110 mmHg diastolic) on at least 2 occasions
Ability to understand study procedures and to provide written informed consent
Disqualifiers
Cerebrovascular events
Acute coronary syndrome
Acute or decompensated heart failure
Any condition preventing ABPM
Trial design
Parallel
Treatments tested in this trial
Postponement of antihypertensive treatment
Other interventionHypertensive blood pressure values in medical in-patients will not be treated during hospitalisation until confirmed by ABPM 4 weeks after hospital discharge
Treatment groups
Trial outcomes
Primary outcomes
Prevalence of persisting new or uncontrolled arterial hypertension
Elevated blood pressure values in ambulatory blood pressure monitoring
Prevalence of a combined hypertensive complication endpoint
Consisting of intracerebral bleeding, ischemic stroke, myocardial infarction, cardiovascular death or cardiovascular re-hospitalization
Prevalence of a combined hypotensive complication endpoint
Consisting of falls, acute kidney injury, electrolyte disturbances, re-hospitalizations due to hypotension, or BP values on ABPM below the lower treatment limit
Secondary outcomes
Clinic blood pressure measurement in mmHg
Documented in the patient documentation
Research blood pressure measurement in mmHg
Standardized blood pressure measurement taken by research staff
Prevalence of previously unknown arterial hypertension
No previously documented diagnosis of arterial hypertension and no antihypertensive treatment
Prevalence of female gender
As reported by participant
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Annina Vischer
Lead sponsor
University Hospital, Basel, Switzerland
Sponsor institution